https://www.selleckchem.com/products/d-4476.html
Most studies found sarcopenia to be a predictor for worse perioperative and oncologic outcomes in patients treated with radical surgery, radiotherapy, or systemic therapy for prostate cancer. However, there is significant heterogeneity across the studies in terms of sarcopenia definition. For a better understanding of the prognostic value of sarcopenia in patients with prostate cancer, large-scale prospective studies are needed. Most studies found sarcopenia to be a predictor for worse perioperative and oncologic outcomes in patients tre
Like
Comment
Share
